First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in …
RR McKay, AK Morgans, ND Shore, C Dunshee… - Cancer Treatment …, 2024 - Elsevier
Introduction Metastatic castration-resistant prostate cancer (mCRPC) remains incurable and
develops from biochemically recurrent PC treated with androgen deprivation therapy (ADT) …
develops from biochemically recurrent PC treated with androgen deprivation therapy (ADT) …
Emerging hormonal agents for the treatment of prostate cancer
E Bochner, S Gold, GV Raj - Expert opinion on emerging drugs, 2022 - Taylor & Francis
Introduction Prostate cancer is the most common solid organ malignancy in men in the
United States. Until recently, treatment options for men with metastatic disease were limited …
United States. Until recently, treatment options for men with metastatic disease were limited …
Added value of prostate-specific antigen density in selecting prostate biopsy candidates among men with elevated prostate-specific antigen and PI-RADS≥ 3 lesions …
Background A significant proportion of patients with positive multiparametric magnetic
resonance imaging (mpMRI; Prostate Imaging-Reporting and Data System [PI-RADS] scores …
resonance imaging (mpMRI; Prostate Imaging-Reporting and Data System [PI-RADS] scores …
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
V Duque-Santana, A Diaz-Gavela, M Recio… - World Journal of …, 2023 - Springer
Purpose To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …
The association of smoking with urinary and sexual function recovery following radical prostatectomy for localized prostate cancer: a systematic review and meta …
J Visscher, M Hiwase, B Bonevski… - Prostate Cancer and …, 2024 - nature.com
Background Urinary and sexual dysfunction after radical prostatectomy remains a major
cause of morbidity, despite widespread availability of pharmacological and rehabilitative …
cause of morbidity, despite widespread availability of pharmacological and rehabilitative …
Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation
BA Erickson, RM Hoffman, J Wachsmuth… - JAMA network …, 2023 - jamanetwork.com
Importance The Veterans Choice Program (VCP) was implemented in 2014 to help veterans
gain broader access to specialized care outside of the Veterans Health Administration (VHA) …
gain broader access to specialized care outside of the Veterans Health Administration (VHA) …
Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro …
Purpose To assess the diagnostic performance of microultrasound-targeted biopsy
(microUSTBx) and systematic biopsy (SBx) in detecting clinically significant prostate cancer …
(microUSTBx) and systematic biopsy (SBx) in detecting clinically significant prostate cancer …
Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study
AM García Vicente, C Lucas Lucas, J Pérez-Beteta… - Scientific Reports, 2024 - nature.com
To validate the performance of automated Prostate Cancer Molecular Imaging Standardized
Evaluation (aPROMISE) in quantifying total prostate disease burden with 18F-DCFPyL …
Evaluation (aPROMISE) in quantifying total prostate disease burden with 18F-DCFPyL …
[HTML][HTML] Advances in localized prostate cancer: a special focus on photothermal therapy
Prostate cancer (PCa) is a high prevalence disease, per 10000 habitants, that tends to
increase with age. This pathology is difficult to detect at an early stage due to the absence of …
increase with age. This pathology is difficult to detect at an early stage due to the absence of …
Outcomes of ablative therapy and radical treatment for prostate cancer: a systematic review and meta-analysis
GM Andrade, FG Manente, PJDD Barroso… - International braz j …, 2024 - SciELO Brasil
Purpose: To compare biochemical recurrence, sexual potency and urinary continence
outcomes of ablative therapy and radical treatment (radical prostatectomy or radiotherapy …
outcomes of ablative therapy and radical treatment (radical prostatectomy or radiotherapy …